Clinical context
Cataract surgery outcomes are not defined by best-corrected visual acuity alone. Refractive accuracy, vision at different distances, spectacle dependence, contrast sensitivity, dysphotopsia and procedural safety all matter. Corneal and macular status, capsular support, cataract density and IOL calculation also shape the final result. A statistically convincing average therefore still has to be interpreted against the characteristics of an individual eye.
What was studied
This multicenter retrospective study compared 14 formulas in 3,738 eyes from 3,738 patients after myopic laser vision correction. Cataract surgery involved 145 U.S. surgeons; biometry used IOLMaster 700 and subjective refraction was recorded 21–90 days later. LASIK or PRK history was surgeon reported without independent verification. Comparators included Haigis-L, Shammas-PL, modern Barrett True K, Cooke K6, EVO 2.0, Hoffer QST and PEARL-DGS with and without posterior corneal curvature, plus Shammas-Cooke and Haigis-TK.
How the evidence was produced
A cohort study describes how outcomes are associated with an exposure or treatment in an observed clinical population. This design is useful for routine practice, uncommon events and longer follow-up, but it remains vulnerable to confounding by indication, baseline risk differences and missing data. An association should not automatically be interpreted as a causal effect.
How to interpret the result
Posterior-corneal biometry improved post-myopic-ablation calculations, particularly in short and steep eyes. Differences were small in typical eyes, so rankings should not replace a validated local pathway. Without complete biometry, Shammas-Cooke was a reasonable fallback but trailed leading methods.
The result should be understood as an estimate for the population studied, not a promise of an individual outcome. Statistical and clinical significance, absolute and relative effects, and prespecified and exploratory analyses should be distinguished. When several endpoints or subgroups are reported, the prespecified primary endpoint for which the study was designed usually provides the most reliable inference.
Clinical applicability
This evidence is most useful as a basis for preoperative discussion and surgical planning. It helps identify which outcomes should be measured and which trade-offs should be explained to patients. The average effect should not be generalized to every IOL, technique or patient without checking eligibility criteria, surgeon experience, biometry, ocular comorbidity and duration of follow-up.
Limitations
This was a database analysis. Laser history lacked verification and ablation data; procedures and timing may differ. Requiring satisfactory vision may exclude complicated eyes. Refraction ranged from 21 to 90 days. Verify IOL models, constants, error centering, eligibility, missing data, center independence, extreme-eye distribution, financial relationships and online-formula access.
Beyond the limitations acknowledged by the authors, confidence is affected by sample size, follow-up duration, missing data, choice of comparator and relevance of the outcomes to routine care. Uncommon complications may remain undetected even in a well-conducted study. External validity is reduced when participants, equipment or investigator expertise differ substantially from everyday settings.
What to verify in the source
In the full paper, verify the protocol, eligibility criteria, baseline group characteristics, primary endpoint definition, confidence intervals, adverse events and losses to follow-up. Funding, conflicts of interest, trial registration and consistency between the published analysis and the original plan deserve separate attention. The DOI or source link below provides access to the primary publication for this check.